title: Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
authors.forename: Daniel
authors.initials: D
authors.lastname: Asz-Sigall
authors.forename: Lirio
authors.initials: L
authors.lastname: López-García
authors.forename: Yvette
authors.initials: Y
authors.lastname: Neme-Yunes
authors.forename: Ricardo
authors.initials: R
authors.lastname: Yuen-Palos
authors.forename: Maria Elisa
authors.initials: ME
authors.lastname: Vega-Memije
authors.forename: Roberto
authors.initials: R
authors.lastname: Arenas
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007917:Leprostatic Agents; D003622:Dapsone; D015242:Ofloxacin; D002991:Clofazimine; D011241:Prednisone; D012293:Rifampin